CYCLACEL PHARMACEUTICALS INC - COM (CYCC)

CUSIP: 23254L603

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
333,819
Share change
+333,819
Total reported value
$1,551,593
Price per share
$4.65
Number of holders
9
Value change
+$1,551,593
Number of buys
9

Quarterly Holders Quick Answers

What is CUSIP 23254L603?
CUSIP 23254L603 identifies CYCC - CYCLACEL PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYCLACEL PHARMACEUTICALS INC - COM (CYCC) as of Q2 2020

As of 30 Jun 2020, CYCLACEL PHARMACEUTICALS INC - COM (CYCC) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 333,819 shares. The largest 9 holders included RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Raymond James Financial Services Advisors, Inc., WEDBUSH SECURITIES INC, Federation des caisses Desjardins du Quebec, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, and BREWIN DOLPHIN LTD. This page lists 9 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.